{"filing":{"accession_number":"0001193125-26-316183","cik":"0001162194","ticker":"LAB","company_name":"STANDARD BIOTOOLS INC.","form":"8-K","filing_date":"2026-07-24","report_date":"2026-07-22","primary_document":"lab-20260722.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526316183/lab-20260722.htm"},"events":[{"id":20496,"run_id":18448,"accession_number":"0001193125-26-316183","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Standard BioTools received a formal notice from Nasdaq on July 22, 2026, indicating failure to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days (until January 19, 2027) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued listing status and trading viability.","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-07-24","form":"8-K","submitted_at":null,"items":[{"id":19869,"accession_number":"0001193125-26-316183","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Standard BioTools received a formal notice from Nasdaq on July 22, 2026, indicating failure to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days (until January 19, 2027) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued listing status and trading viability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T20:39:39.326675+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19869,"accession_number":"0001193125-26-316183","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Standard BioTools received a formal notice from Nasdaq on July 22, 2026, indicating failure to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days (until January 19, 2027) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued listing status and trading viability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T20:39:39.326675+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-07-24"}]}